key: cord-0810588-lwq3q7pt
authors: Zhang, Bin; Zhang, Yuan; Xiong, Lei; Li, Yuzhe; Zhang, Yunliang; Zhao, Jiuliang; Jiang, Hui; Li, Can; Liu, Yunqi; Liu, Xindong; Liu, Haofei; Ping, Yi-Fang; Zhang, Qiangfeng Cliff; Zhang, Zheng; Bian, Xiu-Wu; Zhao, Yan; Hu, Xiaoyu
title: CD127 imprints functional heterogeneity to diversify monocyte responses in human inflammatory diseases
date: 2020-11-10
journal: bioRxiv
DOI: 10.1101/2020.11.10.376277
sha: 473a83fbe79952c6f4b4c8538721f8a680f510a8
doc_id: 810588
cord_uid: lwq3q7pt

Studies on human monocytes historically focused on characterization of bulk responses, whereas functional heterogeneity is largely unknown. Here, we identified an inducible population of CD127-expressing human monocytes under inflammatory conditions and named the subset M127. M127 is nearly absent in healthy individuals yet abundantly present in patients with infectious and inflammatory conditions such as COVID-19 and rheumatoid arthritis. Multiple genomic and functional approaches revealed unique gene signatures of M127 and unified anti-inflammatory properties imposed by the CD127-STAT5 axis. M127 expansion correlated with mild COVID-19 disease outcomes. Thereby, we phenotypically and molecularly characterized a human monocyte subset marked by CD127 that retained anti-inflammatory properties within the pro-inflammatory environments, uncovering remarkable functional diversity among monocytes and signifying M127 as a potential therapeutic target for human inflammatory disorders.

Abstract: 32 Studies on human monocytes historically focused on characterization of bulk responses, whereas functional 33 heterogeneity is largely unknown. Here, we identified an inducible population of CD127-expressing human 34 monocytes under inflammatory conditions and named the subset M127. M127 is nearly absent in healthy 35 individuals yet abundantly present in patients with infectious and inflammatory conditions such as 19 and rheumatoid arthritis. Multiple genomic and functional approaches revealed unique gene signatures of 37 M127 and unified anti-inflammatory properties imposed by the CD127-STAT5 axis. M127 expansion 38 correlated with mild COVID-19 disease outcomes. Thereby, we phenotypically and molecularly 39 characterized a human monocyte subset marked by CD127 that retained anti-inflammatory properties within 40 the pro-inflammatory environments, uncovering remarkable functional diversity among monocytes and 41 signifying M127 as a potential therapeutic target for human inflammatory disorders.

blood origin accumulate at the sites of infection and/or inflammation and produce large quantities of pro-48 inflammatory mediators including cytokines and chemokines 4 , exacerbating disease outcomes by promoting 49 the vicious inflammation cycle 5, 6 . Under homeostasis, human monocyte heterogeneity has been 50 conventionally defined by bimodal expression of CD14 and CD16 7, 8 . However, understanding of functional 51 heterogeneity of human monocytes under inflammatory conditions is limited, which imposes conceptual and 52 technical barriers of therapeutically targeting human inflammatory diseases 9 , a particularly prominent issue 53 amid the global menace of COVID-19 10 . Here, through multiomics analyses of human samples including 54 extensive profiling at the single cell level, we defined a subset of human inflammatory monocytes uniquely 55 marked by the expression of CD127 (thus termed M127) that were abundantly present in inflamed tissues of 56 COVID-19 and RA patients. Mechanistic investigations and integrative computational approaches further 57 revealed common molecular and functional features of M127 across multiple inflammatory disease 58 conditions. 59 60 CD127, encoded by IL7R, is generally considered a lymphoid lineage marker that is predominantly 61 expressed and functional on T cells and innate lymphoid cells 11 . Immunohistochemical analyses of 62 pulmonary autopsy samples revealed minimal CD127 expression in alveoli from individuals who deceased 63 due to non-infectious causes yet robust staining in patients succumbing to SARS-CoV-2 infection (Fig. 1a) . 64 Unexpectedly, in SARS-CoV-2 infected lung tissues, CD127 signals appeared in the regions of CD68 65 positivity (Fig. 1a) , implying plausible expression of CD127 in monocytes/macrophages, which was 66 confirmed by co-localization of CD127 and CD68 signals on immunofluorescently stained sections of 67 autopsied COVID-19 lung tissues (Fig. 1b) . Monocytes/macrophage (CD14 high CD68 high ) expression of 68 CD127 was further corroborated at the transcriptome level by single cell RNA sequencing (scRNA-seq) 69 analyses of bronchoalveolar lavage fluid (BALF) from nine COVID-19 patients with clinical manifestations 70 ranging from mild (n = 3) to severe (n = 6) (Extended Data Fig. 1a ). Strikingly, a distinct IL7R + population 71 (Fig. 1c, d) was revealed to constitute 21% of BALF monocytes/macrophages (Fig. 1e) . Moreover, in contrast 72 to the predicted dominance by lymphoid cells, the majority (64%) of IL7R + cells in COVID-19 BALF were 73 of monocyte/macrophage lineage (Fig. 1f) . 74 75 To validate whether CD127 expression on monocytes/macrophages can be generalized to other human 76 inflammatory conditions such as RA, peripheral blood mononuclear cells (PBMCs) from 16 anti-77 inflammatory treatment naïve RA patients were analyzed for CD127 expression. Compared with the minimal 78 levels of CD127 in CD14 + monocytes from healthy donors, all RA patients examined displayed markedly 79 elevated expression of CD127 on blood monocytes at the protein and mRNA levels (Fig. 1g,h) . In RA blood 80 4 monocytes, IL7R expression correlated with the expression of a major pathogenic factor, TNF (Fig. 1h, i) 12 . 81 To probe CD127 at the primary sites of inflammation, RA synovial tissue scRNA-seq data sets from 18 82 patients 13 (Extended Data Fig. 1b) were analyzed for IL7R expression, which showed strong positivity in a 83 distinct population (Fig. 1j ,k) that represented nearly 22% of synovial monocytes (Fig. 1l) . Taken together, 84 expression of CD127 on a subset of inflammatory monocytes/macrophages is likely a hallmark of human 85 inflammatory conditions testified in multiple disease settings (COVID-19 and RA) and multiple tissues 86 (infected lungs, peripheral blood and inflamed joints). 87 88 In order to pursue in-depth investigation of CD127 + monocytes/macrophages, we wished to recapitulate 89 such phenotypes in vitro using infectious and inflammatory stimuli. Stimulation of human PBMCs from 90 healthy donors with toll-like receptor (TLR) ligands led to drastic increase of monocytic CD127 at the protein 91 and mRNA levels, with the exception of TLR3 agonist poly(I:C) (Fig. 2a,b) . Upregulation of CD127 was 92 dynamic, peaking around 6 h post LPS stimulation (Fig. 2c, d) , dependent on canonical TLR signaling 93 modules such as IKK and p38 , and observed in all three currently defined human 94 monocyte subpopulations (Fig. 2e and Extended Data Fig. 2f, g) . In contrast to human monocytes, LPS failed 95 to upregulate CD127 in murine peripheral blood monocytes (Extended Data Fig. 3a -c) and macrophages from 96 multiple tissue sources (data not shown), suggesting human-specific nature of CD127 induction. In addition 97 to TLR stimulations that mimicked infectious conditions, we wished to identify factors that led to CD127 98 expression in chronic inflammatory diseases and pursued TNF as a plausible candidate as its levels correlated 99 with CD127 expression (Fig. 1i) . TNF treatment consistently upregulated CD127 in monocytes, albeit to a 100 lesser extent than LPS (Fig. 2f,g) . Importantly, clinically applied TNF blockade treatment significantly 101 reduced IL7R expression in RA monocytes (Fig. 2h ), further solidifying a role for TNF in upregulation of 102 CD127 in vivo. Next, we wished to investigate whether CD127 in activated monocytes was functional given 103 that another subunit of IL-7 receptor, the IL2RG-encoding common gamma chain, was constitutively 104 expressed in human monocytes (Extended Data Fig. 3d ). IL-7 treatment robustly induced STAT5 tyrosine 105 phosphorylation in LPS-activated monocytes but not in resting monocytes ( Fig. 2i ) with T cells serving as 106 positive controls (Extended Data Fig. 3e ), indicating that activated human monocytes were competent for IL-107 7 receptor signaling. 108 109 Given the heterogeneity of CD127 expression, we reasoned that activated human monocytes may 110 display functional diversity and subjected LPS-activated monocytes to single cell expression profiling. 111 Unsupervised hierarchical clustering revealed four groups of cells with differential gene expression patterns 112 (Fig. 3a,b) . Interestingly, IL7R exhibited a gradient pattern among four clusters, with the highest expression 113 in cluster 1 and the lowest in cluster 4 (Fig. 3c) . To quantitatively assess the inflammatory phenotypes of 114 these cells, we devised a numeric index 'inflammatory score' based on an algorithm 14 reflecting expression 115 levels of 8 representative prototypical inflammatory genes (see 'Methods' for details). Inflammatory score 116 inversely correlated with the expression of IL7R, with the highest level shown for cluster 4 that exhibited the 117 5 lowest level of IL7R (Fig. 3d) , a trend that could also be clearly visualized for individual inflammatory genes 118 (Fig. 3e) . To validate the differences of inflammatory responses observed from single cell analyses, we sorted 119 CD127 high and CD127 low LPS-activated monocytes (Fig. 3f) . Consistent with the single cell results, 120 CD127(IL7R) low monocytes produced significantly higher levels of inflammatory mediators such as IL-6 and 121 TNF (Fig. 3g,h) , demonstrating that within a highly defined system consisting of purified monocytes and a 122 single stimulus, human monocytes displayed the remarkably diverse range of inflammatory responses. Upon characterizing the hypo-inflammatory phenotypes of CD127 high cells in vitro, we next wished to 144 validate these findings in vivo in human disease settings. In BALF monocytes/macrophages from COVID-145 19 patients, IL7R + population did not extensively overlap with the highly inflammatory cells and exhibited 146 minimal inflammatory properties (Fig. 4a,b) . Consistent with the in vitro observations, IL7R + cells expressed 147 heightened levels of MAF relative to the highly inflammatory monocytes (Extended Data Fig. 6a ). 148 Importantly, in mild COVID-19 patients, IL7R + cells constituted 48% of all BALF monocytes/macrophages 149 yet in stark contrast, such percentage was merely 17% in severe COVID-19 patients (Fig. 4c) . The differential 150 IL7R patterns in monocytes were not due to the global differences in expression levels as lymphocytic IL7R 151 did not significantly differ between mild and severe patients (Extended Data Fig. 6b ). These results indicated 152 that CD127 indeed marked a population of hypo-inflammatory monocytes/macrophages in vivo and 153 suggested that the prevalence of IL7R + monocytes/macrophages likely correlated with subdued inflammation 154 6 and favorable disease outcomes. In addition to COVID-19, IL7R + population in RA synovial monocytes and 155 peripheral blood monocytes were also largely non-overlapping with the highly inflammatory counterparts 156 and displayed minimal inflammatory features (Fig. 4d ,e and Extended Data Fig. 6c,d) . In summary, we identified a subset of monocytes marked by CD127 in human infectious and 173 inflammatory diseases but not in mice, and named this subset M127 (Extended Data Fig. 7) . We further 174 characterized the inflammatory signals that induced M127 and recapitulated M127 phenotypes with an in 175 vitro system. CD127 did not only serve as a surface marker for this population but also actively transmitted 176 local IL-7 cues 17 to promote a STAT5-coordiated anti-inflammatory program, resulting in hypo-177 inflammatory phenotypes amid the overall inflammatory tissue environments. As of the knowledge of the 178 current study, M127 from multiple disease conditions and multiple tissues such as COVID-19 lungs and RA 179 joints shared common functional features and gene signatures, albeit it would be interesting and desirable to 180 assess whether the depicted M127 phenotypes could be observed in additional human disease settings. Given 181 the unique presence of this population in human inflammatory diseases, especially the correlation of M127 182 expansion with favorable disease outcomes in COVID-19, it is highly conceivable to propose M127 as a 183 potential therapeutic target for inflammatory disorders. Assay for transposase-accessible chromatin coupled with high-throughput sequencing (ATAC-seq) 326 Human CD14 + monocytes from healthy donors were stimulated with 10 ng/ml of LPS for 6 h, and CD127 high 327 and CD127 low populations for each donor were sorted by FACS. Cells were pelleted by centrifugation for 10 328 min at 500 g 4°C using a swing rotor with low acceleration and brake settings. Cell pellets were washed once 329 with 1 × PBS and cells were pelleted again by centrifugation using the previous settings. Cell pellets were 330 re-suspended in 50 μl of lysis buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3.0 mM MgCl2, 0.5% NP-40) 331 and nuclei were pelleted by centrifugation for 30 min at 500 g, 4°C using a swing rotor with low acceleration 332 and brake settings. Supernatant was discarded and nuclei were re-suspended in 50 μl reaction buffer Cufflinks (v2.2.1) 26 . Differential gene expression between CD127 high and CD127 lwo monocytes from three 379 donors was identified using DESeq2 (v1.27.9) 27 . Genes with p-value < 0.05 and mean (FPKM+1) fold 380 changes (CD127 high /CD127 low ) ≥ 1.5 or ≤ 0.67 among three donors were defined as highly expressed genes 381 in CD127 high monocytes or highly expressed genes in CD127 low monocytes, respectively. The Cell Ranger Software Suite (v.3.1.0) was used to perform sample de-multiplexing, barcode 408 processing and single-cell 5′ unique molecular identifier (UMI) counting, and gene-barcode matrices were 409 generated for LPS-treated human CD14 + monocytes and RA patient's PBMCs. The gene-barcode matrices 410 were loaded as Seurat objects, and quality control for each cell was performed with criteria for LPS-treated 411 human CD14 + monocytes (gene number between 200 and 4,500, UMI count > 1,000 and mitochondrial gene 412 13 percentage < 0.15) and RA PBMCs (gene number between 200 and 6,000, UMI count > 1,000 and 413 mitochondrial gene percentage < 0.1). After quality control, top 2,000 variable genes were identified, and 414 gene expression scaling, PCA and UMAP clustering were performed for each data set. Marker genes for each 415 cluster in each scRNA-seq data set were identified by using FindAllMarkers function in Seurat. According 416 to the expression of well-studied PBMC marker genes, each cluster of RA PBMCs was annotated with certain 417 cell type, and monocyte clusters were extracted for downstream analysis. respectively. (f, g) CD127 high and CD127 low populations were isolated from 6 h LPS-stimulated CD14 + 587 monocytes by FACS (f) and the mRNA levels of IL6 and TNF in two populations were measured by qPCR 588 (g). Relative expression was normalized to internal control (GAPDH) and shown relative to CD127 high sample. 

intensities (MFI) from five independent experiments for IL-6 and eleven independent experiments for TNF 594 (right) are shown. **P<0.01, ***P<0.001 by paired Student's t test. Data are shown as means  SD. (i) CD14 + 595 monocytes were transfected with negative control or IL7R specific short interfering RNA (siControl or 596 siIL7R). Two days post transfection, cells were stimulated with LPS (10 ng/ml

Relative expression was normalized to internal 598 control (GAPDH) and expressed relative to LPS untreated siControl sample. *P<0.05 by paired Student's t 599 test. (j) Three healthy donors' CD127 high and C127 low monocytes were sorted as in (F), and generation of 600

ATAC-seq data sets were performed for two monocyte populations from each donor. Pie graph shows the 601 percentages of feature open chromatin regions (OCR) in CD127 high and C127 low monocytes in total OCRs

Three ATAC-seq data sets 603 were combined, and average ATAC-seq signals were calculated in combined ATAC-seq data set for 604 CD127 high and C127 low monocytes around feature OCRs in CD127 high monocytes. (l) Motif enrichment 605 analysis in CD127 high monocyte featured open chromatin regions. Top 5 most enriched transcription factor 606 binding motifs are shown, and x-axis is -log10(p-value) for each enriched motif. Binomial distribution was 607 used for p-value calculation. (m) CD14+ monocytes were pretreated with STAT5 inhibitor (100 μM) for 2 h 608 and then were stimulated with LPS (10 ng/ml). mRNA levels of IL6 (LPS 6 h) and TNF (LPS 3 h) were 609 measured using qPCR

Infla high cells for each disease condition were subgrouped as top 20% inflammatory cells by 615 inflammatory score in mono/mac from COVID-19 BALF, RA synovial monocytes and RA blood monocytes, 616 respectively. Venn diagrams (upper) show the extent of overlap between IL7R + cells and infla high cells, and 617 box plots (bottom) show the inflammatory score distribution in IL7R + cells and infla high cells in mono/mac 618 from COVID-19 BALF (a), RA synovial monocytes and RA blood monocytes

Heat maps show the expression of IL7R and eight inflammatory genes for 620 inflammatory score calculation in IL7R + cells and infla high cells in mono

The scaled average expression levels for 622 each gene and percentages of cell expressing each gene in each group were represented by color and size of 623 the corresponding dots, respectively. (c) Mono/mac cells from COVID-19 patients' BALF were subgrouped 624 by the diagnosed disease severity. Violin plot (upper) shows the expression of IL7R in BALF mono/mac 625 from mild or severe COVID-19 patients. Pie graphs on the bottom show the percentage of IL7R + cells in 626 BALF mono/mac from mild or severe COVID-19 patients as indicated. (f) UMAP projection of integrated 627 monocytes from COVID-19 BALF, RA synovial cavity and LPS-treated monocytes. Nine monocyte clusters 628 by unsupervised clustering were indicated by different colors in plot. (g) UMAP projection of integrated 629 monocytes in (f). IL7R expression among cells were expressed by color as indicated

cluster by highest IL7R expression among clusters. (i) For populations of COVID-19 BALF monocytes, RA 632 synovial monocytes and LPS-treated monocytes, heat map shows the correlation between cluster 2 cells in 633 each monocytes population and all nine clusters in each monocytes population, respectively. (j) The stacked 634 violin plot shows the expression of top 25 cluster 2 signature genes in all nine monocyte clusters in (f)

Median expression levels for each gene in each cluster were expressed by color as indicated

Extended Data Figure 1. Clustering analyses of scRNA-seq data sets 639 (a) UMAP projection of broncho-alveolar lavage fluid (BALF) cells from COVID-19 patients. Cell type 640 annotations were labeled for each cluster. Monocyte/macrophage clusters (CD14 high CD68 high ) were used for 641 the subsequent analyses. (b) t-SNE projection of synovial cells from RA patients

Monocyte clusters (CD14 high ) were used for the subsequent analyses

Extended Data Figure 2. CD127 upregulation in activated human monocytes is dependent on 647 canonical TLR signaling and observed in all monocyte subsets. 648 (a, b) PBMCs form healthy donors were pretreated with DMSO or 10 μM SB203580 or 10 μM

Bay 11) for 30 min and subsequently stimulated with or without 10 ng/ml LPS for 6 hours as indicated. The 650 protein levels of CD127 were measured by flow cytometry and was shown as representative FACS 651 distribution (a) and cumulative percentages (b) in CD14 + monocytes. Each data point represents the result 652 from an independent experiment with cells obtained from a healthy donor. ***P<0.001 by unpaired Student's 653 t test. Data are shown as means  SD of multiple

(c) CD14 + monocytes were isolated form healthy 655 donors' PBMCs, and were pretreated with DMSO or 10 μM SB203580 or 10 μM Bay 11-7082 (Bay 11) for 656 30 min and subsequently stimulated with or without 10 ng/ml LPS for 6 h as indicated. The mRNA levels of 657 IL7R were measured by qPCR. The relative expression was normalized to internal control (GAPDH) and 658 expressed relative to the untreated sample

SB203580 n = 660 6, Bay 11-7082 n = 3. (d, e) CD14 + monocytes were transfected with negative control or MAP3K3 specific 661 short interfering RNAs. Two days post transfection, cells were stimulated with LPS (10 ng/ml) for 3 h. Knock 662 down efficiency of MAP3K3 was examined (d), and mRNA induction of IL7R by LPS stimulation in 663 siControl and siMAP3K3 transfected cells was measured by qPCR (e). Relative expression was normalized 664 26 to internal control (GAPDH) and expressed relative to LPS

Student's t test. IL7R expression data are shown as means  SD of three independent experiments with cells 666 from one healthy donor for each data set. (f, g) Three monocyte populations were gated by CD14 and CD16 667 expression in flow cytometry analysis of human PBMCs. CD127 was also stained in PBMCs with or without 668 LPS stimulation, and CD127 upregulation in three human monocyte populations was analyzed by gating 669 strategy shown in (f)

Extended Data Figure 3. Human but not mouse activated monocytes are CD127 positive and 674 functionally competent for IL-7 receptor signaling

Gating strategy for CD11b + mouse monocytes and CD3 + mouse lymphocytes from red blood cell

lysed mouse peripheral blood cells. (b, c) Mouse blood cells (RBC lysed) were treated with or without 100

ng/ml LPS for different time points as indicated. The expression of CD127 (b) and MHC-II (c) on mouse 678

CD11b + monocytes was analyzed by flow cytometry. (d) Human CD14 + monocytes were treated with

Each data point represents 680 the result from an independent experiment with cells obtained from a healthy donor. Relative expression was 681 normalized to GAPDH as internal control. Data are shown as means  SD of four independent experiments. 682 (e) Human CD14 + monocytes were pretreated with 10 ng/ml LPS for 6 h, and subsequently stimulated with 683 recombinant human IL-7 (10 ng/ml) for the indicated time. Meanwhile, CD3 + T cells from the same donor 684 were treated with 10 ng/ml IL-7 for the indicated time

690 (a) Heat map shows the ATAC-seq signals in OCRs featured in CD127 high monocytes and in CD127 low 691 monocytes from three independent experiments with three blood donors. The ATAC-seq reads count was 692 normalized (per 10 million mapped reads) and then log10(n + 1) transformed for expression in heat map

Pie graph shows the genomic distribution of CD127 high monocyte-featured OCRs. (c) Average ChIP-seq 694 signals of H3K27ac and H3K4me1 in LPS activated monocytes were assessed around CD127 high monocyte-695 featured OCRs and expressed by different colors as

Each data point represents the result from an 712 independent experiment with cells obtained from a healthy donor. *P<0.05 by paired Student's t test. Data 713 are shown as means  SD of four independent experiments. (d) CD14 + monocytes were pretreated with 714 STAT5 inhibitor (100 μM) for 2 h and then were stimulated with LPS (10 ng/ml) for 6 h. mRNA of MAF 715 30 was measured by qPCR. Relative expression is normalized to internal control (GAPDH) and expressed 716 relative to DMSO treated sample. Each data point represents the result from an independent experiment with 717 cells obtained from a healthy donor. ***P<0.001 by paired Student's t test. The results from six independent 718 experiments are shown. (e, f) CD14 + monocytes were transfected with negative control or MAF specific short 719 interfering RNA (siControl or siMAF). Two days post transfection, knockdown efficiency was assessed by 720 measuring MAF mRNA with qPCR (e left, relative expression is normalized to internal control (GAPDH) 721 and expressed relative to siControl group) and MAF protein levels with immunoblotting (e right). Two days 722 post transfection, cells were stimulated with LPS (10 ng/ml) for 3 h and mRNA levels of IL6 and TNF were 723 measured by qPCR (f). Relative expression was normalized to internal control (GAPDH) and expressed 724 relative to LPS untreated siControl sample. Each data point represents the result from an independent 725 experiment with cells obtained from a healthy donor. *P<0.05, **P<0.01 by paired Student's t test. The 726 results from four independent experiments are shown. (g) Occupancy of STAT5 on the MAF transcription 727 start site (TSS) upstream GAS motif was assessed by ChIP

Extended Data Figure 6. CD127 expression designates a functionally distinct monocyte subset 734 (a) Violin plot shows the MAF expression distribution in IL7R + cells and infla high cells in 735 monocytes/macrophages from COVID-19 patients' BALF in Fig. 4a. (b) Lymphoid cells from

Violin plot shows the expression of IL7R 737 in BALF lymphoid cells from mild or severe COVID-19 patients. (c) UMAP projection of PBMCs from RA 738 patient. Cell type annotations were labeled for each cluster. (d) Heat map shows the expression of hallmark 739 genes in different cell clusters from RA PBMCs. The scaled average expression levels of marker genes and 740 percentage of cell expressing marker genes were expressed by color and size of each dot corresponding to 741 cell clusters

Ten clusters by unsupervised clustering were 743 indicated by different colors in plot. (f) UMAP projection of integrated monocytes/macrophages in (e)

FABP4 expression in cells was quantitatively visualized by the indicated colors. Cells corresponding to 745

Cluster 5 were highlighted by dotted line as alveolar macrophages given the specific FABP4 expression 746 pattern. (g) The stacked violin plot shows the expression of top 5 cluster 5 signature genes in all ten clusters 747 shown in (e)

Extended Data Figure 7. M127 represents a unique hypo-inflammatory monocyte population in

Upregulation of CD127 754 is a unified hallmark event for human monocyte activation under various inflammatory conditions including 755

M127, display unique 756 gene signatures and subdued inflammatory phenotypes imposed by CD127-STAT5 signaling. As a result, 757 CD127 levels inversely correlate with the inflammatory capacity of human monocytes. Identification and 758 characterization of M127 highlight the previously underappreciated functional diversity among human

We thank the patients and their families for their contribution to scientific research. 489 We also thank clinical staffs and the COVID-19 Pathology Team from Third Military Medical University 

TCCAACCGGCAGCAATGTAT TGACCAACAGAGCGACAGAG